Regulation of sulfotransferase and UDP-Glucuronosyltransferase gene expression by the PPARs

PPAR Research

Volumn , Issue , 2009, Pages

  Runge Morris, Melissa ^a   Kocarek, Thomas A ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; CELL NUCLEUS RECEPTOR; CHOLESTEROL; CIGLITAZONE; CIPROFIBRATE; CLOFIBRATE; DEXAMETHASONE; DIETHYLHEXYLPHTHALATE; FARNESOID X RECEPTOR; FENOFIBRIC ACID; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; LIVER ENZYME; LIVER X RECEPTOR AGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIRINIXIC ACID; ROSIGLITAZONE; SULFOTRANSFERASE; TROGLITAZONE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

CELL DIFFERENTIATION; DRUG MECHANISM; DRUG METABOLISM; ENZYME ACTIVATION; ENZYME MECHANISM; ENZYME METABOLISM; GENE EXPRESSION REGULATION; HUMAN; KERATINOCYTE; LIVER; NONHUMAN; REVIEW; SULFONATION; TRANSCRIPTION REGULATION;

EID: 69249222641     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2009/728941     Document Type: Review

References (138)

1. Robinson E., Grieve D. J., Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease Pharmacology Therapeutics 2009 122 3 246 263
2. Trcsik D., Szanto A., Nagy L., Oxysterol signaling links cholesterol metabolism and inflammation via the liver X receptor in macrophages Molecular Aspects of Medicine 2009 30 3 134 152
3. Chapman E., Best M. D., Hanson S. R., Wong C.-H., Sulfotransferases: structure, mechanism, biological activity, inhibition, and synthetic utility Angewandte Chemie International Edition 2004 43 27 3526 3548
4. Strott C. A., Sulfonation and molecular action Endocrine Reviews 2002 23 5 703 732
5. Dooley T. P., Haldeman-Cahill R., Joiner J., Wilborn T. W., Expression profiling of human sulfotransferase and sulfatase gene superfamilies in epithelial tissues and cultured cells Biochemical and Biophysical Research Communications 2000 277 1 236 245
6. Falany C. N., Krasnykh V., Falany J. L., Bacterial expression and characterization of a cDNA for human liver estrogen sulfotransferase Journal of Steroid Biochemistry and Molecular Biology 1995 52 6 529 539
7. Kester M. H. A., van Dijk C. H., Tibboel D., Sulfation of thyroid hormone by estrogen sulfotransferase Journal of Clinical Endocrinology and Metabolism 1999 84 7 2577 2580
8. Kitada H., Miyata M., Nakamura T., Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity The Journal of Biological Chemistry 2003 278 20 17838 17844
9. Engel S. R., Purdy R. H., Grant K. A., Characterization of discriminative stimulus effects of the neuroactive steroid pregnanolone Journal of Pharmacology and Experimental Therapeutics 2001 297 2 489 495
10. Akwa Y., Ladurelle N., Covey D. F., Baulieu E.-E., The synthetic enantiomer of pregnenolone sulfate is very active on memory in rats and mice, even more so than its physiological neurosteroid counterpart: distinct mechanisms? Proceedings of the National Academy of Sciences of the United States of America 2001 98 24 14033 14037
11. Shimizu C., Fuda H., Yanai H., Strott C. A., Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and postnatal expression, kinetic analysis of isoforms, and comparison with prototypical SULT2A1 Endocrinology 2003 144 4 1186 1193
12. Shimada M., Yoshinari K., Tanabe E., Identification of ST2A1 as a rat brain neurosteroid sulfotransferase mRNA Brain Research 2001 920 1-2 222 225
13. Lewis A. J., Walle U. K., King R. S., Kadlubar F. F., Falany C. N., Walle T., Bioactivation of the cooked food mutagen N -hydroxy-2-amino-1-methyl-6- phenylimidazo[4,5- b ]pyridine by estrogen sulfotransferase in cultured human mammary epithelial cells Carcinogenesis 1998 19 11 2049 2053
14. Banoglu E., Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens Current Drug Metabolism 2000 1 1 1 30
15. Glatt H., Boeing H., Engelke C. E. H., Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects Mutation Research 2001 482 1-2 27 40
16. Petrotchenko E. V., Pedersen L. C., Borchers C. H., Tomer K. B., Negishi M., The dimerization motif of cytosolic sulfotransferases FEBS Letters 2001 490 1-2 39 43
17. Nagata K., Yamazoe Y., Pharmacogenetics of sulfotransferase Annual Review of Pharmacology and Toxicology 2000 40 159 176
18. Rutgers M., Heusdens F. A., Visser T. J., Deiodination of iodothyronine sulfamates by type I iodothyronine deiodinase of rat liver Endocrinology 1991 129 3 1375 1381
19. Kester M. H. A., Kaptein E., Roest T. J., Characterization of human iodothyronine sulfotransferases Journal of Clinical Endocrinology and Metabolism 1999 84 4 1357 1364
20. Li X., Clemens D. L., Cole J. R., Anderson R. J., Characterization of human liver thermostable phenol sulfotransferase (SULT1A1) allozymes with 3, 3 ′,5-triiodothyronine as the substrate Journal of Endocrinology 2001 171 3 525 532
21. Sakakibara Y., Yanagisawa K., Takami Y., Nakayama T., Suiko M., Liu M.-C., Molecular cloning, expression, and functional characterization of novel mouse sulfotransferases Biochemical and Biophysical Research Communications 1998 247 3 681 686 (Pubitemid 28418451)
22. Tsoi C., Falany C. N., Morgenstern R., Swedmark S., Identification of a new subfamily of sulphotransferases: cloning and characterization of canine SULT1D1 Biochemical Journal 2001 356 3 891 897
23. Falany J. L., Falany C. N., Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines Cancer Research 1996 56 7 1551 1555
24. Falany J. L., Azziz R., Falany C. N., Identification and characterization of cytosolic sulfotransferases in normal human endometrium Chemico-Biological Interactions 1998 109 13 329 339
25. Tong M. H., Jiang H., Liu P., Lawson J. A., Brass L. F., Song W.-C., Spontaneous fetal loss caused by placental thrombosis in estrogen sulfotransferase-deficient mice Nature Medicine 2005 11 2 153 159
26. Javitt N. B., Lee Y. C., Shimizu C., Fuda H., Strott C. A., Cholesterol and hydroxycholesterol sulfotransferases: identification, distinction from dehydroepiandrosterone sulfotransferase, and differential tissue expression Endocrinology 2001 142 7 2978 2984
27. Falany C. N., Vazquez M. E., Kalb J. M., Purification and characterization of human liver dehydroepiandrosterone sulphotransferase Biochemical Journal 1989 260 3 641 646
28. Her C., Szumlanski C., Aksoy I. A., Weinshilboum R. M., Human jejunal estrogen sulfotransferase and dehydroepiandrosterone sulfotransferase Immunochemical characterization of individual variation Drug Metabolism and Disposition 1996 24 12 1328 1335
29. Parker C. R. Jr., Falany C. N., Stockard C. R., Stankovic A. K., Grizzle W. E., Immunohistochemical localization of dehydroepiandrosterone sulfotransferase in human fetal tissues Journal of Clinical Endocrinology and Metabolism 1994 78 1 234 236
30. Duanmu Z., Weckle A., Koukouritaki S. B., Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver Journal of Pharmacology and Experimental Therapeutics 2006 316 3 1310 1317
31. Labrie F., Blanger A., Luu-The V., DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging Steroids 1998 63 5-6 322 328
32. Her C., Wood T. C., Eichler E. E., Human hydroxysteroid sulfotransferase SULT2B1: two enzymes encoded by a single chromosome 19 gene Genomics 1998 53 3 284 295
33. Kohjitani A., Fuda H., Hanyu O., Strott C. A., Cloning, characterization and tissue expression of rat SULT2B1a and SULT2B1b steroid/sterol sulfotransferase isoforms: divergence of the rat SULT2B1 gene structure from orthologous human and mouse genes Gene 2006 367 1-2 66 73
34. Dongning H. E., Meloche C. A., Dumas N. A., Frost A. R., Falany C. N., Different subcellular localization of sulphotransferase 2B1b in human placenta and prostate Biochemical Journal 2004 379 3 533 540
35. Higashi Y., Fuda H., Yanai H., Expression of cholesterol sulfotransferase (SULT2B1b) in human skin and primary cultures of human epidermal keratinocytes Journal of Investigative Dermatology 2004 122 5 1207 1213
36. Geese W. J., Raftogianis R. B., Biochemical characterization and tissue distribution of human SULT2B1 Biochemical and Biophysical Research Communications 2001 288 1 280 289
37. He D., Frost A. R., Falany C. N., Identification and immunohistochemical localization of Sulfotransferase 2B1b (SULT2B1b) in human lung Biochimica et Biophysica Acta 2005 1724 1-2 119 126
38. Koizumi M., Momoeda M., Hiroi H., Expression and regulation of cholesterol sulfotransferase (SULT2B1b) in human endometrium. Fertility and Sterility. In press
39. Dumas N. A., He D., Frost A. R., Falany C. N., Sulfotransferase 2B1b in human breast: differences in subcellular localization in African American and Caucasian women Journal of Steroid Biochemistry and Molecular Biology 2008 111 35 171 177
40. Yanai H., Javitt N. B., Higashi Y., Fuda H., Strott C. A., Expression of cholesterol sulfotransferase (SULT2B1b) in human platelets Circulation 2004 109 1 92 96
41. Falany C. N., He D., Dumas N., Frost A. R., Falany J. L., Human cytosolic sulfotransferase 2B1: isoform expression, tissue specificity and subcellular localization Journal of Steroid Biochemistry and Molecular Biology 2006 102 15 214 221
42. Fuda H., Lee Y. C., Shimizu C., Javitt N. B., Strott C. A., Mutational analysis of human hydroxysteroid sulfotransferase SULT2B1 isoforms reveals that exon 1B of the SULT2B1 gene produces cholesterol sulfotransferase, whereas exon 1A yields pregnenolone sulfotransferase The Journal of Biological Chemistry 2002 277 39 36161 36166
43. Baulieu E. E., Neurosteroids: a novel function of the brain Psychoneuroendocrinology 1998 23 8 963 987
44. Kohjitani A., Fuda H., Hanyu O., Strott C. A., Regulation of SULT2B1a (pregnenolone sulfotransferase) expression in rat C6 glioma cells: relevance of AMPA receptor-mediated NO signaling Neuroscience Letters 2008 430 1 75 80
45. Takahashi S., Sakakibara Y., Mishiro E., Molecular cloning, expression, and characterization of mouse amine N -sulfotransferases Biochemical and Biophysical Research Communications 2008 375 4 531 535
46. Falany C. N., Xie X., Wang J., Ferrer J., Falany J. L., Molecular cloning and expression of novel sulphotransferase-like cDNAs from human and rat brain Biochemical Journal 2000 346, part 3 857 864
47. Liyou N. E., Buller K. M., Tresillian M. J., Localization of a brain sulfotransferase, SULT4A1, in the human and rat brain: an immunohistochemical study Journal of Histochemistry and Cytochemistry 2003 51 12 1655 1664
48. Freimuth R. R., Wiepert M., Chute C. G., Wieben E. D., Weinshilboum R. M., Human cytosolic sulfotransferase database mining: identification of seven novel genes and pseudogenes Pharmacogenomics Journal 2004 4 1 54 65
49. Gamage N., Barnett A., Hempel N., Human sulfotransferases and their role in chemical metabolism Toxicological Sciences 2006 90 1 5 22
50. Lindsay J., Wang L.-L., Li Y., Zhou S.-F., Structure, function and polymorphism of human cytosolic sulfotransferases Current Drug Metabolism 2008 9 2 99 105
51. Alnouti Y., Klaassen C. D., Regulation of sulfotransferase enzymes by prototypical microsomal enzyme inducers in mice Journal of Pharmacology and Experimental Therapeutics 2008 324 2 612 621
52. Fan L.-Q., You L., Brown-Borg H., Brown S., Edwards R. J., Corton J. C., Regulation of phase I and phase II steroid metabolism enzymes by PPAR activators Toxicology 2004 204 2-3 109 121
53. Fang H.-L., Strom S. C., Cai H., Falany C. N., Kocarek T. A., Runge-Morris M., Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor transcription factor Molecular Pharmacology 2005 67 4 1257 1267
54. Lampe M. A., Williams M. L., Elias P. M., Human epidermal lipids: characterization and modulations during differentiation Journal of Lipid Research 1983 24 2 131 140
55. Epstein E. H. Jr., Williams M. L., Elias P. M., The epidermal cholesterol sulfate cycle Journal of the American Academy of Dermatology 1984 10 5 866 868
56. Epstein E. H. Jr., Bonifas J. M., Barber T. C., Haynes M., Cholesterol sulfotransferase of newborn mouse epidermis Journal of Investigative Dermatology 1984 83 5 332 335
57. Kagehara M., Tachi M., Harii K., Iwamori M., Programmed expression of cholesterol sulfotransferase and transglutaminase during epidermal differentiation of murine skin development Biochimica et Biophysica Acta 1994 1215 1-2 183 189
58. Kashiwagi M., Kuroki T., Huh N.-H., Specific inhibition of hair follicle formation by epidermal growth factor in an organ culture of developing mouse skin Developmental Biology 1997 189 1 22 32
59. Jetten A. M., George M. A., Nervi C., Boone L. R., Rearick J. I., Increased cholesterol sulfate and cholesterol sulfotransferase activity in relation to the multi-step process of differentiation in human epidermal keratinocytes Journal of Investigative Dermatology 1989 92 2 203 209
60. Johnson G. A., Baker C. A., Knight K. A., Minoxidil sulfotransferase, a marker of human keratinocyte differentiation Journal of Investigative Dermatology 1992 98 5 730 733
61. Kmves L. G., Hanley K., Jiang Y., Induction of selected lipid metabolic enzymes and differentiation-linked structural proteins by air exposure in fetal rat skin explants Journal of Investigative Dermatology 1999 112 3 303 309
62. Kiguchi K., Kagehara M., Higo R., Iwamori M., DiGiovanni J., Alterations in cholesterol sulfate and its biosynthetic enzyme during multistage carcinogenesis in mouse skin Journal of Investigative Dermatology 1998 111 6 973 981
63. Yamamoto S., Jiang H., Kato R., Involvement of prostaglandin E 2 in the tumor promoter phorbol ester-caused increase in epidermal cholesterol sulfotransferase activity Carcinogenesis 1991 12 6 1145 1147
64. Lee K. A., Fuda H., Lee Y. C., Negishi M., Strott C. A., Pedersen L. C., Crystal structure of human cholesterol sulfotransferase (SULT2B1b) in the presence of pregenenolone and 3'-phosphoadenosine 5 ′ -phosphate The Journal of Biological Chemistry 2003 278 44953 44599
65. Denning M. F., Kazanietz M. G., Blumberg P. M., Yuspa S. H., Cholesterol sulfate activates multiple protein kinase C isoenzymes and induces granular cell differentiation in cultured murine keratinocytes Cell Growth and Differentiation 1995 6 12 1619 1626
66. Kuroki T., Ikuta T., Kashiwagi M., Cholesterol sulfate, an activator of protein kinase C mediating squamous cell differentiation: a review Mutation Research 2000 462 2-3 189 195
67. Denning M. F., Epidermal keratinocytes: regulation of multiple cell phenotypes by multiple protein kinase C isoforms International Journal of Biochemistry and Cell Biology 2004 36 7 1141 1146
68. Kawabe S., Ikuta T., Ohba M., Cholesterol sulfate activates transcription of transglutaminase 1 gene in normal human keratinocytes Journal of Investigative Dermatology 1998 111 6 1098 1102
69. Ohba M., Ishino K., Kashiwagi M., Induction of differentiation in normal human keratinocytes by adenovirus-mediated introduction of the and isoforms of protein kinase C Molecular and Cellular Biology 1998 18 9 5199 5207
70. Kallen J. A., Schlaeppi J.-M., Bitsch F., X-ray structure of the hROR LBD at 1.63: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of ROR Structure 2002 10 12 1697 1707
71. Kallen J., Schlaeppi J.-M., Bitsch F., Delhon I., Fournier B., Crystal structure of the human ROR Ligand binding domain in complex with cholesterol sulfate at 2.2 The Journal of Biological Chemistry 2004 279 14 14033 14038
72. Bitsch F., Aichholz R., Kallen J., Geisse S., Fournier B., Schlaeppi J.-M., Identification of natural ligands of retinoic acid receptor-related orphan receptor ligand-binding domain expressed in Sf9 cellsa mass spectrometry approach Analytical Biochemistry 2003 323 1 139 149
73. Jiang Y. J., Kim P., Elias P. M., Feingold K. R., LXR and PPAR activators stimulate cholesterol sulfotransferase type 2 isoform 1b in human keratinocytes Journal of Lipid Research 2005 46 12 2657 2666
74. Little J. M., Drake R. R., Vonk R., Kuipers F., Lester R., Radominska A., Characterization of human liver microsomal UDP-glycosyltransferases using photoaffinity analogs Journal of Pharmacology and Experimental Therapeutics 1995 273 3 1551 1559
75. Owens I. S., Basu N. K., Banerjee R., UDP-glucuronosyltransferases: gene structures of UGT1 and UGT2 families Methods in Enzymology 2005 400 1 22
76. Caldwell J., Matern S., Bock S. W., Gerock W., Glucuronic acid conjugation in the context of the metabolic conjugation of xenobiotics Advances in Glucuronide Conjugation 1985 Boston, Mass, USA MTP Press 7 20
77. Dutton G. J., Glucuronidation of Drugs and Other Compounds 1980 Boca Raton, Fla, USA CRC Press
78. Barbier O., Villeneuve L., Bocher V., The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor and target gene The Journal of Biological Chemistry 2003 278 16 13975 13983
79. King C. D., Rios G. R., Green M. D., Tephly T. R., UDP- glucuronosyltransferases Current Drug Metabolism 2000 1 2 143 161
80. Loi C.-M., Young M., Randinitis E., Vassos A., Koup J. R., Clinical pharmacokinetics of troglitazone Clinical Pharmacokinetics 1999 37 2 91 104
81. Watanabe Y., Nakajima M., Yokoi T., Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10 Drug Metabolism and Disposition 2002 30 12 1462 1469
82. Yoshigae Y., Konno K., Takasaki W., Ikeda T., Characterization of UDP-glucuronosyltransferases (UGTS) involved in the metabolism of troglitazone in rats and humans Journal of Toxicological Sciences 2000 25 5 433 441
83. Prueksaritanont T., Zhao J. J., Ma B., Mechanistic studies on metabolic interactions between gemfibrozil and statins Journal of Pharmacology and Experimental Therapeutics 2002 301 3 1042 1051
84. Prueksaritanont T., Tang C., Qiu Y., Mu L., Subramanian R., Lin J. H., Effects of fibrates on metabolism of statins in human hepatocytes Drug Metabolism and Disposition 2002 30 11 1280 1287
85. Burchell B., Coughtrie M. W. H., UDP-glucuronosyltransferases Pharmacology and Therapeutics 1989 43 2 261 289
86. Zhou J., Zhang J., Xie W., Xenobiotic nuclear receptor-mediated regulation of UDP-glucuronosyltransferases Current Drug Metabolism 2005 6 4 289 298
87. Shelby M. K., Cherrington N. J., Vansell N. R., Klaassen C. D., Tissue mRNA expression of the rat UDP-glucuronosyltransferase gene family Drug Metabolism and Disposition 2003 31 3 326 333
88. Tukey R. H., Strassburg C. P., Human UDP-glucuronosyltransferases: metabolism, expression, and disease Annual Review of Pharmacology and Toxicology 2000 40 581 616
89. Mackenzie P. I., Owens I. S., Burchell B., The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence Pharmacogenetics 1997 7 4 255 269
90. Ritter J. K., Chen F., Sheen Y. Y., A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini The Journal of Biological Chemistry 1992 267 5 3257 3261
91. Gong Q.-H., Cho J. W., Huang T., Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus Pharmacogenetics 2001 11 4 357 368
92. Lvesque E., Girard H., Journault K., Lpine J., Guillemette C., Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus Hepatology 2007 45 1 128 138
93. Girard H., Lvesque E., Bellemare J., Journault K., Caillier B., Guillemette C., Genetic diversity at the UGT1 locus is amplified by a novel 3 ′ alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity Pharmacogenetics and Genomics 2007 17 12 1077 1089
94. Owens I. S., Ritter J. K., The novel bilirubin/phenol UDP-glucuronosyltransferase UGT1 gene locus: implications for multiple nonhemolytic familial hyperbilirubinemia phenotypes Pharmacogenetics 1992 2 3 93 108
95. Kato Y., Ikushiro S.-I., Emi Y., Hepatic UDP-glucuronosyltransferases responsible for glucuronidation of thyroxine in humans Drug Metabolism and Disposition 2008 36 1 51 55
96. Barbier O., Trottier J., Kaeding J., Caron P., Verreault M., Lipid-activated transcription factors control bile acid glucuronidation Molecular and Cellular Biochemistry 2009 326 1-2 3 8
97. Barbier O., Duran-Sandoval D., Pineda-Torra I., Kosykh V., Fruchart J.-C., Staels B., Peroxisome proliferator-activated receptor induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme The Journal of Biological Chemistry 2003 278 35 32852 32860
98. Gall W. E., Zawada G., Mojarrabi B., Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7 Journal of Steroid Biochemistry and Molecular Biology 1999 70 13 101 108
99. Trottier J., Verreault M., Grepper S., Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver Hepatology 2006 44 5 1158 1170
100. Hess R., Staubli W., Riess W., Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat Nature 1965 208 5013 856 858
101. Reddy J. K., Possible properties of microbodies (peroxisomes). Microbody proliferation and hypolipidemic drugs Journal of Histochemistry and Cytochemistry 1973 21 11 967 971
102. Gibson G. G., Orton T. C., Tamburini P. P., Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid) Biochemical Journal 1982 203 1 161 168
103. Foliot A., Drocourt J. L., Etienne J. P., Housset E., Fiessinger J. N., Christoforov B., Increase in the hepatic glucuronidation and clearance of bilirubin in clofibrate treated rats Biochemical Pharmacology 1977 26 6 547 549
104. Fournel S., Magdalou J., Thomassin J., Structure-dependent induction of bilirubin glucuronidation and lauric acid 12-hydroxylation by arylcarboxylic acids chemically related to clofibrate Biochimica et Biophysica Acta 1985 842 2-3 202 213
105. Fournel S., Magdalou J., Pinon P., Siest G., Differential induction profile of drug-metabolizing enzymes after treatment with hypolipidaemic agents Xenobiotica 1987 17 4 445 457
106. Raza H., Levine W. G., Chowdhury N. R., Chowdhury J. R., Microsomal azoreduction and glucuronidation in the metabolism of dimethylaminoazobenzene by the rat liver Xenobiotica 1987 17 6 669 677 (Pubitemid 17121202)
107. Mounie J., Champion L., Goudonnet H., Escousse A., Truchot R. C., Inductive effects of fenofibrate and metabolism of phenobarbital Fundamental and Clinical Pharmacology 1988 2 4 259 265
108. Boiteux-Antoine A.-F., Magdalou J., Fournel-Gigleux S., Siest G., Comparative induction of drug-metbolizing enzymes by hypolipidaemic compounds General Pharmacology 1989 20 4 407 412
109. Visser T. J., Kaptein E., van Toor H., Glucuronidation of thyroid hormone in rat liver: effects of in vivo treatment with microsomal enzyme inducers and in vitro assay conditions Endocrinology 1993 133 5 2177 2186
110. Ikushiro S.-I., Emi Y., Iyanagi T., Identification and analysis of drug-responsive expression of UDP- glucuronosyltransferase family 1 (UGT1) isozyme in rat hepatic microsomes using anti-peptide antibodies Archives of Biochemistry and Biophysics 1995 324 2 267 272
111. Viollon-Abadie C., Lassere D., Debruyne E., Nicod L., Carmichael N., Richert L., Phenobarbital, -naphthoflavone, clofibrate, and pregnenolone-16 -carbonitrile do not affect hepatic thyroid hormone UDP-glucuronosyl transferase activity, and thyroid gland function in mice Toxicology and Applied Pharmacology 1999 155 1 1 12
112. Viollon-Abadie C., Bigot-Lasserre D., Nicod L., Carmichael N., Richert L., Effects of model inducers on thyroxine UDP-glucuronosyl-transferase activity in vitro in rat and mouse hepatocyte cultures Toxicology in Vitro 2000 14 6 505 512
113. Kutz K., Kandler H., Gugler R., Fevery J., Effect of clofibrate on the metabolism of bilirubin, bromosulphophthalein and indocyanine green and on the biliary lipid composition in Gilberts syndrome Clinical Science 1984 66 4 389 397
114. Dragacci S., Hamar-Hansen C., Fournel-Gigleux S., Lafaurie C., Magdalou J., Siest G., Comparative study of clofibric acid and bilirubin glucuronidation in human liver microsomes Biochemical Pharmacology 1987 36 22 3923 3927
115. Barter R. A., Klaassen C. D., Rat liver microsomal UDP- glucuronosyltransferase activity toward thyroxine: characterization, induction, and form specificity Toxicology and Applied Pharmacology 1992 115 2 261 267
116. Genchi G., Wang W., Barua A., Bidlack W. R., Olson J. A., Formation of -glucuronides and of -galacturonides of various retinoids catalyzed by induced and noninduced microsomal UDP-glucuronosyltransferases of rat liver Biochimica et Biophysica Acta 1996 1289 2 284 290
117. Pless D., Gouze J. N., Senay C., Characterization of the UDP-glucuronosyltransferases involved in the glucuronidation of an antithrombotic thioxyloside in rat and humans Drug Metabolism and Disposition 1999 27 5 588 595
118. Luci S., Kluge H., Hirche F., Eder K., Clofibrate increases hepatic triiodothyronine (T 3)- and thyroxine (T 4)-glucuronosyltransferase activities and lowers plasma T 3 and T 4 concentrations in pigs Drug Metabolism and Disposition 2006 34 11 1887 1892
119. Jemnitz K., Veres Z., Monostory K., Vereczkey L., Glucuronidation of thyroxine in primary monolayer cultures of rat hepatocytes: in vitro induction of UDP-glucuronosyltranferases by methylcholanthrene, clofibrate, and dexamethasone alone and in combination Drug Metabolism and Disposition 2000 28 1 34 37
120. Arand M., Coughtrie M. W. H., Burchell B., Oesch F., Robertson L. W., Selective induction of bilirubin UDP-glucuronosyl-transferase by perfluorodecanoic acid Chemico-Biological Interactions 1991 77 1 97 105
121. Clementi M., Di Gianantonio E., Fabris L., Inheritance of hyperbilirubinemia: evidence for a major autosomal recessive gene Digestive and Liver Disease 2007 39 4 351 355
122. Shelby M. K., Klaassen C. D., Induction of rat UDP- glucuronosyltransferases in liver and duodenum by microsomal enzyme inducers that activate various transcriptional pathways Drug Metabolism and Disposition 2006 34 10 1772 1778
123. Richert L., Lamboley C., Viollon-Abadie C., Effects of clofibric acid on mRNA expression profiles in primary cultures of rat, mouse and human hepatocytes Toxicology and Applied Pharmacology 2003 191 2 130 146
124. Luukkanen L., Taskinen J., Kurkela M., Kostiainen R., Hirvonen J., Finel M., Kinetic characterization of the 1A subfamily of recombinant human UDP-glucuronosyltransferases Drug Metabolism and Disposition 2005 33 7 1017 1026
125. Senekeo-Effenberger K., Chen S., Brace-Sinnokrak E., Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3-xylidino)-2- pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor activation Drug Metabolism and Disposition 2007 35 3 419 427
126. Verreault M., Senekeo-Effenberger K., Trottier J., The liver X-receptor alpha controls hepatic expression of the human bile acid-glucuronidating UGT1A3 enzyme in human cells and transgenic mice Hepatology 2006 44 2 368 378
127. Runge-Morris M., Wu W., Kocarek T. A., Regulation of rat hepatic hydroxysteroid sulfotransferase (SULT2-40/41) gene expression by glucocorticoids: evidence for a dual mechanism of transcriptional control Molecular Pharmacology 1999 56 6 1198 1206
128. Fang H.-L., Abdolalipour M., Duanmu Z., Regulation of glucocorticoid-inducible hydroxysteroid sulfotransferase (SULT2A-40/41) gene transcription in primary cultured rat hepatocytes: role of CCAAT/enhancer- binding protein liver-enriched transcription factors Drug Metabolism and Disposition 2005 33 1 147 156
129. Sonoda J., Xie W., Rosenfeld J. M., Barwick J. L., Guzelian P. S., Evans R. M., Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR) Proceedings of the National Academy of Sciences of the United States of America 2002 99 21 13801 13806
130. Lehmann J. M., McKee D. D., Watson M. A., Willson T. M., Moore J. T., Kliewer S. A., The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions Journal of Clinical Investigation 1998 102 5 1016 1023
131. Fang H.-L., Strom S. C., Ellis E., Positive and negative regulation of human hepatic hydroxysteroid sulfotransferase (SULT2A1) gene transcription by rifampicin: roles of hepatocyte nuclear factor 4 and pregnane X receptor Journal of Pharmacology and Experimental Therapeutics 2007 323 2 586 598
132. Assem M., Schuetz E. G., Leggas M., Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice The Journal of Biological Chemistry 2004 279 21 22250 22257
133. Drocourt L., Ourlin J.-C., Pascussi J.-M., Maurel P., Vilarem M.-J., Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes The Journal of Biological Chemistry 2002 277 28 25125 25132
134. Song C. S., Echchgadda I., Seo Y.-K., An essential role of the CAAT/enhancer binding protein- in the vitamin D-induced expression of the human steroid/bile acid-sulfotransferase (SULT2A1) Molecular Endocrinology 2006 20 4 795 808
135. Tontonoz P., Mangelsdorf D. J., Liver X receptor signaling pathways in cardiovascular disease Molecular Endocrinology 2003 17 6 985 993
136. Uppal H., Saini S. P. S., Moschetta A., Activation of LXRs prevents bile acid toxicity and cholestasis in female mice Hepatology 2007 45 2 422 432
137. Song C., Hiipakka R. A., Liao S., Auto-oxidized cholesterol sulfates are antagonistic ligands of liver X receptors: implications for the development and treatment of atherosclerosis Steroids 2001 66 6 473 479
138. Miyata M., Matsuda Y., Tsuchiya H., Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase Drug Metabolism and Pharmacokinetics 2006 21 4 315 323